{
    "2018-01-31": [
        [
            {
                "time": "",
                "original_text": "[路演]康泰生物：去年疫苗行业已恢复 公司已进入快速发展时期",
                "features": {
                    "keywords": [
                        "疫苗",
                        "行业恢复",
                        "快速发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[路演]康泰生物：预计今年完成十三价肺炎疫苗临床试验",
                "features": {
                    "keywords": [
                        "十三价肺炎疫苗",
                        "临床试验",
                        "预计完成"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[路演]康泰生物：预计今年底开始搬迁深圳生产基地",
                "features": {
                    "keywords": [
                        "生产基地",
                        "搬迁",
                        "深圳"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[路演]康泰生物：一类苗保持较高的市场占有率",
                "features": {
                    "keywords": [
                        "一类苗",
                        "市场占有率",
                        "较高"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【国信转债】康泰转债申购价值分析：疫苗业务高增，成长性可期",
                "features": {
                    "keywords": [
                        "康泰转债",
                        "疫苗业务",
                        "高增",
                        "成长性"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "春节前64家公司限售股解禁，市值近800亿元",
                "features": {
                    "keywords": [
                        "限售股",
                        "解禁",
                        "市值",
                        "800亿元"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "低流通市值，适度参与 | 康泰转债发行定价及申购建议",
                "features": {
                    "keywords": [
                        "低流通市值",
                        "适度参与",
                        "康泰转债",
                        "发行定价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}